 Keith Neeves
Concepts (355)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 27 | 2022 | 397 | 5.280 |
Why?
| | Microfluidic Analytical Techniques | 19 | 2018 | 74 | 4.070 |
Why?
| | Thrombosis | 20 | 2023 | 319 | 3.940 |
Why?
| | Blood Coagulation | 20 | 2021 | 229 | 3.630 |
Why?
| | Fibrin | 9 | 2018 | 62 | 2.420 |
Why?
| | Hemostasis | 8 | 2021 | 71 | 2.360 |
Why?
| | Platelet Aggregation | 14 | 2022 | 99 | 2.050 |
Why?
| | Platelet Activation | 7 | 2023 | 71 | 1.550 |
Why?
| | Thrombin | 5 | 2020 | 146 | 1.500 |
Why?
| | Colloids | 4 | 2020 | 60 | 1.470 |
Why?
| | Hemophilia A | 4 | 2023 | 72 | 1.440 |
Why?
| | Fibrinolysis | 4 | 2021 | 175 | 1.410 |
Why?
| | Drug Delivery Systems | 6 | 2022 | 309 | 1.400 |
Why?
| | Microfluidics | 10 | 2020 | 54 | 1.300 |
Why?
| | Tissue Plasminogen Activator | 2 | 2021 | 245 | 1.170 |
Why?
| | Platelet Adhesiveness | 6 | 2019 | 15 | 1.150 |
Why?
| | Vascular System Injuries | 3 | 2017 | 70 | 1.050 |
Why?
| | Lab-On-A-Chip Devices | 5 | 2021 | 43 | 1.010 |
Why?
| | Collagen | 9 | 2019 | 443 | 0.990 |
Why?
| | Blood Platelet Disorders | 2 | 2023 | 10 | 0.940 |
Why?
| | Magnetic Fields | 5 | 2022 | 23 | 0.890 |
Why?
| | Nanoparticles | 4 | 2019 | 328 | 0.890 |
Why?
| | Biomimetics | 2 | 2014 | 43 | 0.870 |
Why?
| | von Willebrand Factor | 5 | 2019 | 60 | 0.870 |
Why?
| | Erythrocytes | 3 | 2018 | 642 | 0.790 |
Why?
| | Plasminogen | 1 | 2021 | 35 | 0.780 |
Why?
| | Nanomedicine | 2 | 2022 | 28 | 0.720 |
Why?
| | Platelet Membrane Glycoproteins | 3 | 2018 | 43 | 0.710 |
Why?
| | Rheology | 3 | 2016 | 94 | 0.700 |
Why?
| | Plasminogen Activators | 1 | 2019 | 8 | 0.690 |
Why?
| | Thromboplastin | 7 | 2018 | 73 | 0.690 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 77 | 0.680 |
Why?
| | Fibrinolysin | 1 | 2019 | 19 | 0.670 |
Why?
| | Models, Biological | 7 | 2020 | 1753 | 0.670 |
Why?
| | Tranexamic Acid | 1 | 2019 | 43 | 0.650 |
Why?
| | Antifibrinolytic Agents | 1 | 2019 | 52 | 0.640 |
Why?
| | Thrombolytic Therapy | 1 | 2019 | 120 | 0.630 |
Why?
| | Drug Carriers | 1 | 2019 | 119 | 0.630 |
Why?
| | Regional Blood Flow | 4 | 2017 | 441 | 0.620 |
Why?
| | Venous Valves | 1 | 2018 | 1 | 0.620 |
Why?
| | Cesium | 1 | 2018 | 19 | 0.620 |
Why?
| | Fibrinogen | 3 | 2017 | 164 | 0.580 |
Why?
| | Torpor | 1 | 2017 | 15 | 0.570 |
Why?
| | Fibrinolytic Agents | 1 | 2019 | 256 | 0.560 |
Why?
| | Genetic Diseases, Inborn | 1 | 2017 | 50 | 0.560 |
Why?
| | Hemorrhage | 2 | 2019 | 673 | 0.540 |
Why?
| | Venous Thrombosis | 1 | 2018 | 143 | 0.530 |
Why?
| | Pharmaceutical Preparations | 3 | 2021 | 171 | 0.520 |
Why?
| | Sciuridae | 1 | 2017 | 145 | 0.510 |
Why?
| | Heating | 1 | 2015 | 18 | 0.510 |
Why?
| | Ferric Compounds | 1 | 2015 | 38 | 0.500 |
Why?
| | Water Pollutants, Chemical | 1 | 2018 | 180 | 0.500 |
Why?
| | Bleeding Time | 1 | 2015 | 5 | 0.500 |
Why?
| | Protein Aggregates | 1 | 2015 | 70 | 0.480 |
Why?
| | Saphenous Vein | 1 | 2015 | 32 | 0.480 |
Why?
| | Chlorides | 1 | 2015 | 138 | 0.480 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2018 | 22 | 0.470 |
Why?
| | Cell Adhesion | 3 | 2014 | 455 | 0.470 |
Why?
| | Humans | 50 | 2023 | 125132 | 0.470 |
Why?
| | Stress, Mechanical | 7 | 2018 | 456 | 0.460 |
Why?
| | Epigastric Arteries | 1 | 2012 | 20 | 0.420 |
Why?
| | Polymers | 4 | 2015 | 476 | 0.420 |
Why?
| | Femoral Vein | 1 | 2012 | 29 | 0.420 |
Why?
| | Animals | 32 | 2022 | 34345 | 0.410 |
Why?
| | Collagen Type I | 1 | 2013 | 112 | 0.410 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 82 | 0.400 |
Why?
| | Extracellular Fluid | 2 | 2013 | 33 | 0.400 |
Why?
| | E-Selectin | 1 | 2012 | 54 | 0.400 |
Why?
| | Nanotubes | 1 | 2012 | 41 | 0.390 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2012 | 63 | 0.380 |
Why?
| | Carotid Arteries | 1 | 2012 | 190 | 0.380 |
Why?
| | Fibrin Clot Lysis Time | 2 | 2021 | 9 | 0.370 |
Why?
| | Cell Separation | 1 | 2012 | 299 | 0.370 |
Why?
| | Factor V | 2 | 2020 | 23 | 0.360 |
Why?
| | Vascular Diseases | 1 | 2013 | 251 | 0.360 |
Why?
| | Hemodynamics | 4 | 2018 | 1093 | 0.350 |
Why?
| | Endothelial Cells | 1 | 2015 | 742 | 0.340 |
Why?
| | Biophysics | 1 | 2010 | 74 | 0.340 |
Why?
| | Factor VIII | 3 | 2020 | 56 | 0.330 |
Why?
| | Blood Flow Velocity | 4 | 2018 | 401 | 0.330 |
Why?
| | Groundwater | 2 | 2020 | 34 | 0.320 |
Why?
| | Receptors, Thrombin | 1 | 2008 | 12 | 0.320 |
Why?
| | Platelet Function Tests | 3 | 2021 | 25 | 0.300 |
Why?
| | Kinetics | 5 | 2018 | 1680 | 0.300 |
Why?
| | Pulmonary Embolism | 2 | 2022 | 183 | 0.300 |
Why?
| | Adenosine Diphosphate | 1 | 2008 | 90 | 0.300 |
Why?
| | Nitric Oxide | 1 | 2013 | 886 | 0.300 |
Why?
| | Membranes, Artificial | 1 | 2008 | 79 | 0.300 |
Why?
| | Porosity | 3 | 2020 | 90 | 0.290 |
Why?
| | Neostriatum | 1 | 2007 | 30 | 0.290 |
Why?
| | Dilatation | 1 | 2007 | 61 | 0.280 |
Why?
| | Computer Simulation | 3 | 2020 | 953 | 0.280 |
Why?
| | Biological Transport | 3 | 2017 | 392 | 0.260 |
Why?
| | Silicon Dioxide | 2 | 2018 | 100 | 0.250 |
Why?
| | Extracellular Matrix | 2 | 2011 | 462 | 0.240 |
Why?
| | Hydrodynamics | 5 | 2019 | 39 | 0.240 |
Why?
| | Equipment Design | 6 | 2016 | 545 | 0.240 |
Why?
| | Microscopy, Electron, Scanning | 3 | 2014 | 202 | 0.220 |
Why?
| | von Willebrand Diseases | 1 | 2023 | 13 | 0.220 |
Why?
| | Shear Strength | 4 | 2019 | 66 | 0.210 |
Why?
| | Gels | 2 | 2015 | 91 | 0.200 |
Why?
| | Leukocyte Elastase | 1 | 2022 | 83 | 0.200 |
Why?
| | Metabolic Flux Analysis | 1 | 2021 | 7 | 0.200 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 92 | 0.190 |
Why?
| | Models, Cardiovascular | 2 | 2016 | 190 | 0.190 |
Why?
| | Respiratory Mucosa | 2 | 2014 | 264 | 0.190 |
Why?
| | Hematocrit | 2 | 2018 | 97 | 0.180 |
Why?
| | Models, Theoretical | 3 | 2019 | 585 | 0.180 |
Why?
| | Mice | 13 | 2022 | 15984 | 0.170 |
Why?
| | Blood Coagulation Tests | 2 | 2021 | 59 | 0.170 |
Why?
| | High-Energy Shock Waves | 1 | 2019 | 4 | 0.170 |
Why?
| | Semaphorins | 2 | 2010 | 23 | 0.170 |
Why?
| | Magnetite Nanoparticles | 1 | 2019 | 27 | 0.170 |
Why?
| | ADAMTS13 Protein | 1 | 2019 | 9 | 0.170 |
Why?
| | Convection | 3 | 2011 | 7 | 0.170 |
Why?
| | Drug Compounding | 1 | 2019 | 91 | 0.160 |
Why?
| | Herpes Zoster | 1 | 2023 | 336 | 0.160 |
Why?
| | Male | 18 | 2023 | 60793 | 0.160 |
Why?
| | Microelectrodes | 3 | 2007 | 33 | 0.160 |
Why?
| | Liposomes | 1 | 2019 | 160 | 0.160 |
Why?
| | Geologic Sediments | 1 | 2018 | 37 | 0.150 |
Why?
| | von Willebrand Disease, Type 1 | 1 | 2017 | 1 | 0.150 |
Why?
| | Robotics | 1 | 2019 | 86 | 0.150 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2018 | 43 | 0.150 |
Why?
| | Hemorheology | 1 | 2017 | 21 | 0.150 |
Why?
| | Phosphatidylserines | 1 | 2018 | 91 | 0.150 |
Why?
| | Viscosity | 2 | 2015 | 91 | 0.150 |
Why?
| | Flow Cytometry | 3 | 2016 | 1108 | 0.140 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 181 | 0.140 |
Why?
| | Antigens, CD | 2 | 2010 | 466 | 0.140 |
Why?
| | Antithrombin III | 1 | 2017 | 7 | 0.140 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 2016 | 4 | 0.140 |
Why?
| | Magnetics | 1 | 2017 | 40 | 0.140 |
Why?
| | Thromboxane A2 | 1 | 2016 | 13 | 0.140 |
Why?
| | Adsorption | 2 | 2020 | 130 | 0.140 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2018 | 435 | 0.140 |
Why?
| | Peptide Hydrolases | 1 | 2017 | 110 | 0.130 |
Why?
| | Adenine | 1 | 2018 | 229 | 0.130 |
Why?
| | Models, Molecular | 1 | 2021 | 1450 | 0.130 |
Why?
| | Blood Cells | 1 | 2015 | 39 | 0.130 |
Why?
| | Piperazines | 1 | 2018 | 331 | 0.130 |
Why?
| | Models, Anatomic | 1 | 2016 | 95 | 0.130 |
Why?
| | Clot Retraction | 1 | 2015 | 1 | 0.120 |
Why?
| | Electrodes | 1 | 2015 | 94 | 0.120 |
Why?
| | Pneumonia | 1 | 2020 | 610 | 0.120 |
Why?
| | Arteries | 1 | 2017 | 257 | 0.120 |
Why?
| | Time Factors | 4 | 2017 | 6780 | 0.120 |
Why?
| | Elastic Modulus | 1 | 2015 | 116 | 0.120 |
Why?
| | Bioreactors | 1 | 2014 | 46 | 0.120 |
Why?
| | Signal Transduction | 4 | 2018 | 4809 | 0.120 |
Why?
| | Toxicity Tests | 1 | 2014 | 28 | 0.120 |
Why?
| | Blood Vessels | 1 | 2016 | 193 | 0.120 |
Why?
| | Hypoxia | 1 | 2020 | 1021 | 0.120 |
Why?
| | Temperature | 1 | 2017 | 635 | 0.120 |
Why?
| | Enzyme Precursors | 1 | 2014 | 15 | 0.120 |
Why?
| | Stroke | 1 | 2023 | 1098 | 0.120 |
Why?
| | Nanotechnology | 2 | 2013 | 121 | 0.110 |
Why?
| | Rats | 5 | 2014 | 5517 | 0.110 |
Why?
| | Factor VIIa | 1 | 2013 | 36 | 0.110 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 317 | 0.110 |
Why?
| | Cysteine Endopeptidases | 1 | 2013 | 61 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2011 | 2512 | 0.110 |
Why?
| | Bronchi | 2 | 2012 | 259 | 0.110 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2014 | 83 | 0.110 |
Why?
| | Azo Compounds | 1 | 2013 | 26 | 0.110 |
Why?
| | Optical Tweezers | 1 | 2013 | 20 | 0.110 |
Why?
| | Materials Testing | 1 | 2015 | 350 | 0.110 |
Why?
| | Models, Chemical | 1 | 2015 | 274 | 0.110 |
Why?
| | Surface Properties | 2 | 2019 | 411 | 0.110 |
Why?
| | International Cooperation | 1 | 2014 | 187 | 0.110 |
Why?
| | Lipid Bilayers | 1 | 2014 | 102 | 0.110 |
Why?
| | Receptor, PAR-2 | 1 | 2012 | 9 | 0.110 |
Why?
| | Fibrillar Collagens | 1 | 2012 | 13 | 0.110 |
Why?
| | Permeability | 1 | 2013 | 155 | 0.110 |
Why?
| | Biomechanical Phenomena | 2 | 2013 | 703 | 0.110 |
Why?
| | Factor VII | 1 | 2012 | 27 | 0.100 |
Why?
| | Receptor, PAR-1 | 1 | 2012 | 22 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2020 | 3823 | 0.100 |
Why?
| | Horses | 1 | 2013 | 110 | 0.100 |
Why?
| | Spectrophotometry | 1 | 2012 | 55 | 0.100 |
Why?
| | Polymerization | 1 | 2013 | 129 | 0.100 |
Why?
| | Microvilli | 1 | 2012 | 70 | 0.100 |
Why?
| | Cells, Cultured | 3 | 2015 | 4159 | 0.100 |
Why?
| | Linear Models | 1 | 2015 | 870 | 0.100 |
Why?
| | Observer Variation | 1 | 2013 | 330 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 832 | 0.100 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 419 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2014 | 356 | 0.100 |
Why?
| | Polystyrenes | 2 | 2011 | 34 | 0.100 |
Why?
| | Protein Binding | 2 | 2020 | 2014 | 0.100 |
Why?
| | Surface Plasmon Resonance | 1 | 2011 | 84 | 0.100 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2011 | 66 | 0.090 |
Why?
| | Microscopy, Atomic Force | 1 | 2011 | 119 | 0.090 |
Why?
| | Lung | 2 | 2020 | 3865 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2014 | 1005 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2013 | 220 | 0.090 |
Why?
| | Cell Membrane | 2 | 2015 | 732 | 0.090 |
Why?
| | Female | 10 | 2023 | 64890 | 0.090 |
Why?
| | Platelet Factor 4 | 2 | 2020 | 22 | 0.090 |
Why?
| | Ozone | 1 | 2011 | 117 | 0.090 |
Why?
| | Neoplasm Proteins | 1 | 2013 | 409 | 0.090 |
Why?
| | Integrins | 1 | 2010 | 84 | 0.090 |
Why?
| | Myocytes, Cardiac | 1 | 2014 | 487 | 0.090 |
Why?
| | Societies, Medical | 1 | 2014 | 754 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 743 | 0.080 |
Why?
| | Absorbable Implants | 1 | 2009 | 38 | 0.080 |
Why?
| | src-Family Kinases | 1 | 2009 | 96 | 0.080 |
Why?
| | Brain Diseases | 1 | 2010 | 143 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2016 | 3047 | 0.080 |
Why?
| | Integrin alpha2beta1 | 1 | 2008 | 3 | 0.080 |
Why?
| | Water | 1 | 2011 | 432 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2020 | 1880 | 0.080 |
Why?
| | Dimethylpolysiloxanes | 1 | 2008 | 10 | 0.080 |
Why?
| | Silicones | 1 | 2008 | 21 | 0.080 |
Why?
| | Hyperlipidemias | 1 | 2009 | 144 | 0.080 |
Why?
| | Cerebral Cortex | 1 | 2011 | 450 | 0.080 |
Why?
| | Cell Membrane Permeability | 1 | 2008 | 90 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 410 | 0.070 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2007 | 8 | 0.070 |
Why?
| | Protein Array Analysis | 1 | 2008 | 63 | 0.070 |
Why?
| | Electrodes, Implanted | 2 | 2006 | 100 | 0.070 |
Why?
| | Molecular Weight | 1 | 2007 | 345 | 0.070 |
Why?
| | Osmolar Concentration | 1 | 2007 | 196 | 0.070 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2010 | 413 | 0.070 |
Why?
| | Tissue Distribution | 1 | 2007 | 342 | 0.070 |
Why?
| | Algorithms | 2 | 2011 | 1618 | 0.070 |
Why?
| | Reference Values | 1 | 2008 | 818 | 0.070 |
Why?
| | Evans Blue | 1 | 2006 | 7 | 0.070 |
Why?
| | Caudate Nucleus | 1 | 2006 | 18 | 0.070 |
Why?
| | Insecta | 1 | 2006 | 71 | 0.070 |
Why?
| | Diffusion | 1 | 2006 | 129 | 0.060 |
Why?
| | Extremities | 1 | 2006 | 116 | 0.060 |
Why?
| | Albumins | 1 | 2006 | 106 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 360 | 0.060 |
Why?
| | Phenotype | 1 | 2013 | 3153 | 0.060 |
Why?
| | Brain | 2 | 2009 | 2639 | 0.060 |
Why?
| | Muscles | 1 | 2006 | 340 | 0.060 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 391 | 0.060 |
Why?
| | Infusion Pumps, Implantable | 1 | 2004 | 20 | 0.060 |
Why?
| | Foreign-Body Reaction | 1 | 2004 | 24 | 0.060 |
Why?
| | Movement | 2 | 2017 | 252 | 0.060 |
Why?
| | Anticoagulants | 2 | 2021 | 587 | 0.060 |
Why?
| | Child, Preschool | 2 | 2017 | 9938 | 0.060 |
Why?
| | Elasticity | 2 | 2015 | 191 | 0.060 |
Why?
| | Immunoblotting | 2 | 2016 | 313 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1885 | 0.050 |
Why?
| | Electric Impedance | 2 | 2014 | 105 | 0.050 |
Why?
| | P-Selectin | 1 | 2022 | 30 | 0.050 |
Why?
| | Apolipoprotein A-I | 1 | 2022 | 28 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 2010 | 1040 | 0.050 |
Why?
| | CD36 Antigens | 1 | 2022 | 42 | 0.050 |
Why?
| | Cystic Fibrosis | 1 | 2011 | 990 | 0.050 |
Why?
| | Young Adult | 2 | 2017 | 11385 | 0.050 |
Why?
| | Exosomes | 1 | 2023 | 92 | 0.050 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 58 | 0.050 |
Why?
| | Arachidonic Acid | 1 | 2022 | 120 | 0.050 |
Why?
| | Mice, Knockout | 3 | 2016 | 2736 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 51 | 0.050 |
Why?
| | Blood Specimen Collection | 1 | 2021 | 34 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5102 | 0.050 |
Why?
| | Plasma | 1 | 2023 | 224 | 0.050 |
Why?
| | Blood Pressure | 1 | 2008 | 1735 | 0.050 |
Why?
| | Chemokine CCL5 | 1 | 2020 | 49 | 0.050 |
Why?
| | Factor Xa | 1 | 2020 | 33 | 0.050 |
Why?
| | Carbon | 1 | 2021 | 178 | 0.050 |
Why?
| | Binding, Competitive | 1 | 2020 | 209 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 241 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 106 | 0.040 |
Why?
| | Phosphorylation | 2 | 2018 | 1694 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 155 | 0.040 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2020 | 19 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2022 | 437 | 0.040 |
Why?
| | Research | 1 | 2023 | 440 | 0.040 |
Why?
| | Adolescent | 2 | 2017 | 19411 | 0.040 |
Why?
| | Catheterization | 2 | 2010 | 161 | 0.040 |
Why?
| | Herpesvirus 3, Human | 1 | 2023 | 390 | 0.040 |
Why?
| | Adult | 3 | 2019 | 33168 | 0.040 |
Why?
| | Motion | 1 | 2019 | 97 | 0.040 |
Why?
| | Rotation | 1 | 2019 | 125 | 0.040 |
Why?
| | Thrombocytopenia | 1 | 2020 | 188 | 0.040 |
Why?
| | Bleomycin | 1 | 2020 | 218 | 0.040 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2017 | 12 | 0.040 |
Why?
| | Serotonin | 1 | 2020 | 328 | 0.040 |
Why?
| | Uncertainty | 1 | 2018 | 113 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2020 | 830 | 0.040 |
Why?
| | Purinergic P2Y Receptor Antagonists | 1 | 2018 | 62 | 0.040 |
Why?
| | Hemostatics | 1 | 2017 | 52 | 0.040 |
Why?
| | Drug Synergism | 1 | 2018 | 344 | 0.040 |
Why?
| | Machine Learning | 1 | 2020 | 353 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1250 | 0.030 |
Why?
| | Cytoplasmic Granules | 1 | 2016 | 102 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 371 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2018 | 227 | 0.030 |
Why?
| | Blood Circulation | 1 | 2015 | 36 | 0.030 |
Why?
| | Miniaturization | 1 | 2015 | 24 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 652 | 0.030 |
Why?
| | Thrombopoiesis | 1 | 2014 | 7 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2018 | 1006 | 0.030 |
Why?
| | Nanostructures | 1 | 2016 | 101 | 0.030 |
Why?
| | Megakaryocytes | 1 | 2014 | 30 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 656 | 0.030 |
Why?
| | Platelet Transfusion | 1 | 2014 | 70 | 0.030 |
Why?
| | Chlorine | 1 | 2014 | 62 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2015 | 186 | 0.030 |
Why?
| | Biomimetic Materials | 1 | 2014 | 69 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3274 | 0.030 |
Why?
| | Erythrocyte Deformability | 1 | 2013 | 13 | 0.030 |
Why?
| | Inhalation Exposure | 1 | 2014 | 112 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1431 | 0.030 |
Why?
| | Gases | 1 | 2013 | 54 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1992 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2014 | 667 | 0.030 |
Why?
| | Pressure | 1 | 2013 | 237 | 0.030 |
Why?
| | Nitrogen | 1 | 2013 | 157 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 317 | 0.020 |
Why?
| | Serum Albumin, Bovine | 1 | 2011 | 68 | 0.020 |
Why?
| | Microtechnology | 1 | 2010 | 4 | 0.020 |
Why?
| | Cell Death | 1 | 2012 | 347 | 0.020 |
Why?
| | Syk Kinase | 1 | 2010 | 16 | 0.020 |
Why?
| | Trachea | 1 | 2012 | 238 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2010 | 25 | 0.020 |
Why?
| | Molecular Dynamics Simulation | 1 | 2012 | 217 | 0.020 |
Why?
| | Catheters | 1 | 2010 | 64 | 0.020 |
Why?
| | Particle Size | 1 | 2011 | 353 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 170 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3326 | 0.020 |
Why?
| | Wound Healing | 1 | 2012 | 298 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2012 | 584 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2612 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2011 | 319 | 0.020 |
Why?
| | Polyglactin 910 | 1 | 2009 | 10 | 0.020 |
Why?
| | Diet, Atherogenic | 1 | 2009 | 7 | 0.020 |
Why?
| | Proline | 1 | 2009 | 71 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1081 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2011 | 291 | 0.020 |
Why?
| | Factor XIIa | 1 | 2008 | 1 | 0.020 |
Why?
| | Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 3 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 29112 | 0.020 |
Why?
| | Plant Proteins | 1 | 2008 | 83 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 3736 | 0.020 |
Why?
| | Amplifiers, Electronic | 1 | 2006 | 9 | 0.020 |
Why?
| | Xylenes | 1 | 2006 | 8 | 0.020 |
Why?
| | Cockroaches | 1 | 2006 | 22 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2009 | 284 | 0.020 |
Why?
| | Electrophysiology | 1 | 2006 | 205 | 0.020 |
Why?
| | Locomotion | 1 | 2006 | 83 | 0.020 |
Why?
| | Transferrin | 1 | 2004 | 41 | 0.020 |
Why?
| | Calcium | 1 | 2010 | 1211 | 0.010 |
Why?
| | Equipment Failure | 1 | 2004 | 117 | 0.010 |
Why?
| | Running | 1 | 2006 | 238 | 0.010 |
Why?
| | Cytokines | 1 | 2011 | 1927 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2017 | 9790 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2004 | 806 | 0.010 |
Why?
| | Aged | 1 | 2017 | 20859 | 0.010 |
Why?
| | Child | 1 | 2017 | 20014 | 0.010 |
Why?
|
|
Neeves's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|